Latest news
Loading news…
Gadeta
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Utrecht, The Netherlands Founded 2015 11-50 employees For Profit
Gadeta is a research and development company that develops immunotherapies for cancer.
Gadeta was acquired by Clade Therapeutics in 2023.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
4
Patents
16
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 10
- Active products
- 12
- Patents granted
- 16
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $9M
Company Info
- Founded
- 2015
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 19
- HQ
- Utrecht, The Netherlands
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Oct 2, 2023
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 1.7
- Trend (90d)
- -0.2
Key People at Gadeta
COO
4
professional contacts at Gadeta
Contact execs at Gadeta →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Gadeta
Loading news…
FAQs about Gadeta
People who checked this page also checked these
Browse the full Acquirezy directory.